business
Abivax stock plunges on cancer signal in ulcerative colitis trial
Abivax stock plunges on cancer signal in ulcerative colitis trial
Read full story on Yahoo Finance → More top storiesAlso covered by
Investing.com
Wedbush upgrades Abivax stock rating on trial data, cuts target
BBC News
More black men to benefit from prostate cancer screening trial
Investing.com
Citizens reiterates Ideaya Biosciences stock rating on trial data
Investing.com
Citizens reiterates Rapport Therapeutics stock rating on competitor trial data
Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop